A new vaccine targeting triple-negative breast cancer (TNBC) has shown promising results in its first human clinical trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback